North America Pharmaceuticals & Healthcare Views

Pages

ERYTECH's Graspa Gains FDA ODD For AML

ERYTECH Pharma's lead product Graspa (erythrocyte-encapsulated L-asparaginase; ERY-ASP) has been granted orphan drug designation (ODD) by the FDA for the treatment of acute myeloid leukaemia (AML).

Read article ›
Lilly Launches Axiron In Germany

Acrux' Axiron (testosterone metered-dose lotion) has been launched in Germany by the company's marketing partner, Eli Lilly, as a testosterone replacement therapy in men for conditions associated...

Read article ›
Agenus Completes 4-Antibody Acquisition

Agenus, a company developing novel immunotherapeutics, including a portfolio of checkpoint modulators (CPMs), anticancer vaccines and adjuvants, has completed its previously announced acquisition of...

Read article ›

Pages